BUZZ-India's Natco Pharma gains as expansion plans support earnings outlook

Reuters12-01
BUZZ-India's Natco Pharma gains as expansion plans support earnings outlook

** Drug maker Natco Pharma's NATP.NS stock up 2.5%; earlier rose as much as 5.22% to 923 rupees

** Rating agency ICRA reaffirms ICRAAA (Stable)/ ICRAA1+ credit ratings of NATP, citing notable market position, strong portfolio of complex generics, R&D capabilities

** Sees NATP's expansion in emerging markets such as Saudi Arabia, Algeria, Morocco, Egypt, Latin America as key positive

** NATP has also incorporated units in Brazil, Canada, Indonesia, Singapore, Philippines, UK and Columbia, to set up front-end presence

** With the expansion, NATP will be able to achieve higher profitability in the upcoming quarters, says ICRA, while flagging potential litigation risks

** NATP down 37% YTD vs 2.6% drop in pharma index .NIPHARM, exchange data shows

(Reporting by Bharath Rajeswaran in Bengaluru)

((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment